IMMUNITYBIO, INC. Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
IMMUNITYBIO, INC. (IBRX) had Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $136.88 million as of 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosureRecurring · last filed 2018-05-07
- 2018-03-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $136.88M.
- 2017-12-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $157.75M.
- 2017-09-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $165.54M.
- 2017-06-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $197.51M.
| Period end | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) as first filed |
|---|---|---|
| 2018-03-31 | $136.88M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $157.75M 10-Q · filed 2018-05-07 | |
| 2017-09-30 | $165.54M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $197.51M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $248.86M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $286.49M 10-K · filed 2018-03-12 | $280.41M 10-K · filed 2017-03-15 |
| 2016-09-30 | $288.98M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $283.47M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $299.72M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $191.48M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |